Your browser doesn't support javascript.
loading
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC).
Welti, Jonathan; Sharp, Adam; Yuan, Wei; Dolling, David; Nava Rodrigues, Daniel; Figueiredo, Ines; Gil, Veronica; Neeb, Antje; Clarke, Matthew; Seed, George; Crespo, Mateus; Sumanasuriya, Semini; Ning, Jian; Knight, Eleanor; Francis, Jeffrey C; Hughes, Ashley; Halsey, Wendy S; Paschalis, Alec; Mani, Ram S; Raj, Ganesh V; Plymate, Stephen R; Carreira, Suzanne; Boysen, Gunther; Chinnaiyan, Arul M; Swain, Amanda; de Bono, Johann S.
Afiliação
  • Welti J; The Institute for Cancer Research, London, United Kingdom.
  • Sharp A; The Institute for Cancer Research, London, United Kingdom.
  • Yuan W; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Dolling D; The Institute for Cancer Research, London, United Kingdom.
  • Nava Rodrigues D; The Institute for Cancer Research, London, United Kingdom.
  • Figueiredo I; The Institute for Cancer Research, London, United Kingdom.
  • Gil V; The Institute for Cancer Research, London, United Kingdom.
  • Neeb A; The Institute for Cancer Research, London, United Kingdom.
  • Clarke M; The Institute for Cancer Research, London, United Kingdom.
  • Seed G; The Institute for Cancer Research, London, United Kingdom.
  • Crespo M; The Institute for Cancer Research, London, United Kingdom.
  • Sumanasuriya S; The Institute for Cancer Research, London, United Kingdom.
  • Ning J; The Institute for Cancer Research, London, United Kingdom.
  • Knight E; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Francis JC; The Institute for Cancer Research, London, United Kingdom.
  • Hughes A; The Institute for Cancer Research, London, United Kingdom.
  • Halsey WS; The Institute for Cancer Research, London, United Kingdom.
  • Paschalis A; GlaxoSmithKline, Collegeville, Pennsylvania.
  • Mani RS; GlaxoSmithKline, Collegeville, Pennsylvania.
  • Raj GV; The Institute for Cancer Research, London, United Kingdom.
  • Plymate SR; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Carreira S; The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Boysen G; The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Chinnaiyan AM; University of Washington/GRECC/VAPSHCS, Seattle, Washington.
  • Swain A; The Institute for Cancer Research, London, United Kingdom.
Clin Cancer Res ; 24(13): 3149-3162, 2018 07 01.
Article em En | MEDLINE | ID: mdl-29555663
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Terapia de Alvo Molecular / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Terapia de Alvo Molecular / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article